Suppr超能文献

评估四个拉丁美洲国家中与艰难梭菌感染相关的风险因素、死亡率和医疗保健利用情况。

Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.

机构信息

Pfizer Inc, Collegeville, PA, USA.

CREOS, Ciudad de Buenos Aires, Argentina.

出版信息

Braz J Infect Dis. 2021 Jan-Feb;25(1):101040. doi: 10.1016/j.bjid.2020.11.005. Epub 2020 Dec 5.

Abstract

BACKGROUND

Clostridioides difficile infection (CDI) is the most common cause of healthcare-associated infections in Western countries. Risk factors, mortality, and healthcare utilization for CDI in Latin America are poorly understood. This study assessed risk factors and burden associated with nosocomial CDI in four Latin American countries.

METHODS

This retrospective, case-control study used databases and medical records from 8 hospitals in Argentina, Brazil, Chile, and Mexico to identify nosocomial CDI cases from 2014 - 2017. Cases were patients aged ≥18 years with diarrhea and a positive CDI test ≥72 h after hospital admission. Two controls (without diarrhea; length of hospital stay [LOS] ≥3 days; admitted ±14 days from case patient; shared same ward) were matched to each case. CDI-associated risk factors were assessed by univariate and multivariable analyses. CDI burden (LOS, in-hospital mortality) was compared between cases and controls.

RESULTS

The study included 481 cases and 962 controls. Mean age and sex were similar between cases and controls, but mean Charlson comorbidity index (4.3 vs 3.6; p < 0.001) and recent hospital admission (35.3% vs 18.8%; p < 0.001) were higher among cases. By multivariable analyses, CDI risk was associated with prior hospital admission within 3 months (odds ratio [OR], 2.08; 95% CI: 1.45, 2.97), recent antibiotic use (ie, carbapenem; OR, 2.85; 95% CI: 1.75, 4.64), acid suppressive therapy use (OR, 1.71; 95% CI: 1.14, 2.58), and medical conditions (ie, renal disease; OR, 1.48; 95% CI: 1.19, 1.85). In-hospital mortality rate (18.7% vs 6.9%; p < 0.001) and mean overall LOS (33.5 vs 18.8 days; p < 0.001) were higher and longer, respectively, in cases versus controls.

CONCLUSION

Antibiotic exposure, preexisting medical conditions, and recent hospital admission were major risk factors for CDI in Argentina, Brazil, Chile, and Mexico. CDI was associated with increased in-hospital risk of death and longer LOS. These findings are consistent with published literature in Western countries.

摘要

背景

艰难梭菌感染(CDI)是西方国家最常见的医源性感染原因。拉丁美洲的 CDI 发病风险因素、死亡率和医疗保健利用情况了解甚少。本研究评估了四个拉丁美洲国家中与医院获得性 CDI 相关的发病风险因素和负担。

方法

本回顾性病例对照研究使用了来自阿根廷、巴西、智利和墨西哥的 8 家医院的数据库和病历,以确定 2014 年至 2017 年间的医院获得性 CDI 病例。病例为年龄≥18 岁、在入院后≥72 小时出现腹泻和 CDI 检测阳性的患者。每个病例匹配了两名无腹泻、住院时间≥3 天、入院时间与病例相差±14 天、入住同一病房的对照。通过单变量和多变量分析评估 CDI 相关发病风险因素。比较病例和对照之间的 CDI 负担(住院时间、院内死亡率)。

结果

该研究纳入了 481 例病例和 962 例对照。病例和对照的平均年龄和性别相似,但病例的 Charlson 合并症指数(4.3 vs 3.6;p<0.001)和近期入院(35.3% vs 18.8%;p<0.001)更高。多变量分析显示,3 个月内有既往住院史(比值比[OR],2.08;95%CI:1.45,2.97)、近期使用抗生素(如碳青霉烯类;OR,2.85;95%CI:1.75,4.64)、使用抑酸治疗(OR,1.71;95%CI:1.14,2.58)和存在合并症(如肾病;OR,1.48;95%CI:1.19,1.85)与 CDI 风险相关。病例组的院内死亡率(18.7% vs 6.9%;p<0.001)和总住院时间(33.5 天 vs 18.8 天;p<0.001)分别更高和更长。

结论

在阿根廷、巴西、智利和墨西哥,抗生素暴露、既往合并症和近期入院是 CDI 的主要发病风险因素。CDI 与院内死亡风险增加和住院时间延长相关。这些发现与西方国家的已发表文献一致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验